top of page

2022 Liver SymposiumWebcasts

Treating NASH in 2022

Souvik Sarkar, MD, PhD | University of California, Davis School of Medicine

Updates on Hepatorenal Syndrome

R. Todd Frederick, MD

Off the Beaten Path Hepatitides

Deepti Dronamraju, MD | Stanford University School of Medicine

DILI: Have We Found the Culprit?

Marina Roytman, MD, FACP | UCSF

Changing Approaches for Hepatocellular Carcinoma (HCC)

Neil Mehta, MD | UCSF

Changing Landscape of
HCC Management

Renu Dhanasekaran, MD | Stanford University

HCV: Reaching Beyond The Cure

Priya Balasubramanian, MD, MPH, FAASLD

DeLIVER Care: Bringing Mobile HCV Services to the San Francisco

Jeff McKinney, FNP-C | University of California, San Francisco

NUC Therapy for Chronic Hepatitis B to Stop or Not to Stop?

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD | Stanford University

Liver Transplantation for
Alcohol-Associated Liver Disease

Allison Kwong MD | Stanford University

Alcohol-Related Liver Disease
in the Era of COVID

Robert Wong, MD, MS | Stanford University

bottom of page